申请人:Merck, Sharp & Dohme Ltd.
公开号:US05681833A1
公开(公告)日:1997-10-28
Compounds of Formula (I), and salts and prodrugs thereof, wherein said formula, R.sup.1 represents certain optionally substituted alkyl or C.sub.3-7 cycloalkyl; R.sup.2 represents (II) or (III), where m is 0, 1, 2 or 3; R.sup.9 is H or C.sub.1-6 alkyl; R.sup.10 is imidazolyl, triazolyl or tetrazolyl, and R.sup.11 is H, C.sub.1-6 alkyl or halo; R.sup.3 is C.sub.1-6 alkyl, halo or NR.sup.6 R.sup.7 ; R.sup.4 is C.sub.1-7 alkyl, C.sub.3-10 cycloalkyl, C.sub.3-10 cycloalkylC.sub.1-4 alkyl, C.sub.6-10 bicycloalkyl, optionally substituted aryl, or NR.sub.12 R.sub.13 ; R.sup.5 is H or C.sub.1-4 alkyl; n is 0, 1, 2 or 3; which are CCK and/or gastrin antagonists useful in therapy.
公式(I)的化合物,以及它们的盐和前药,其中所述公式中,R.sup.1代表某些可选地取代的烷基或C.sub.3-7环烷基;R.sup.2代表(II)或(III),其中m为0、1、2或3;R.sup.9为H或C.sub.1-6烷基;R.sup.10为咪唑基、三唑基或四唑基,且R.sup.11为H、C.sub.1-6烷基或卤素;R.sup.3为C.sub.1-6烷基、卤素或NR.sup.6 R.sup.7;R.sup.4为C.sub.1-7烷基、C.sub.3-10环烷基、C.sub.3-10环烷基C.sub.1-4烷基、C.sub.6-10双环烷基、可选地取代的芳基,或NR.sub.12 R.sub.13;R.sup.5为H或C.sub.1-4烷基;n为0、1、2或3;它们是有用的治疗药物,用作CCK和/或胃泌素拮抗剂。